Kovshova, T. S., Boiko, S. A., Merkulova, M. A., Osipova, N. S., Moiseeva, N. I., Malinovskaya, J. A., . . . Gelperina, S. E. (2023). Development of Injectable Formulation of 4’-O-benzyloxycarbonyl-etoposide Derivative Based on Human Serum Albumin for the Chemotherapy of Breast Cancer. LLC Center of Pharmaceutical Analytics (LLC «CPHA»).
Chicago Style (17th ed.) CitationKovshova, T. S., S. A. Boiko, M. A. Merkulova, N. S. Osipova, N. I. Moiseeva, Ju. A. Malinovskaya, S. N. Mantrov, and S. E. Gelperina. Development of Injectable Formulation of 4’-O-benzyloxycarbonyl-etoposide Derivative Based on Human Serum Albumin for the Chemotherapy of Breast Cancer. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2023.
MLA (9th ed.) CitationKovshova, T. S., et al. Development of Injectable Formulation of 4’-O-benzyloxycarbonyl-etoposide Derivative Based on Human Serum Albumin for the Chemotherapy of Breast Cancer. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2023.